肠道微生物与多种病因的心力衰竭之间的因果关联:孟德尔的随机化研究
Xinming Xu1,2, Safraz Anwar1,2, Yunpeng Shang1
1Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, 311121 Hangzhou, Zhejiang, China.
Reviews in cardiovascular medicine
|February 9, 2026
概括
这项研究发现,较高水平的肠道细菌Peptostreptococcaceae可能会降低高血压心脏病的风险. 进一步的研究可以探索这种联系,用于新的心力衰竭治疗.
科学领域:
- 微生物组研究的研究.
- 心血管疾病遗传学 心血管疾病遗传学
- 门德尔的随机化研究.
背景情况:
- 肠道微生物群在心力衰竭 (HF) 中的作用是公认的,但与HF病因的因果关系尚不清楚.
- 了解肠道微生物群对不同类型的HF的影响对于有针对性的干预至关重要.
研究的目的:
- 通过使用孟德尔随机化来研究遗传决定的肠道微生物特征和心力衰竭之间的因果关系.
- 确定可能影响HF风险及其亚型的特定肠道微生物种群.
主要方法:
- 采用了两个样本的孟德尔随机化 (MR) 分析.
- 利用全基因组关联研究数据来研究肠道微生物特征 (MiBioGen联盟) 和HF亚型 (FinnGen第7版).
- 选择了19个单核酸多态 (SNP),代表了18个肠道微生物种群作为仪器变量.
主要成果:
- 确定了肠道细菌家族Peptostreptococcaceae与高血压心脏病风险之间的显著逆因果关系 (OR:0.355,p < 0.001).
- 观察到其他微生物种类与HF或前体条件的暗示性,但不具有统计学意义的因果关系.
结论:
- 基因预测Peptostreptococcaceae的丰富与降低患高血压心脏病的风险有因果关系.
- 这些发现表明,Peptostreptococcaceae介导的途径是预防和治疗高血压相关高血压的潜在治疗标.
相关概念视频
01:29Heart Failure II: Pathophysiology
987
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
987
01:17Pathophysiology of Heart Failure
3.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.9K
01:27Heart Failure I: Introduction
937
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
937
01:22Heart Failure VI: Adjunct Therapies
385
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
385
01:22Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
01:30Heart Failure V: Medical Management
352
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
352